Bausch Health Companies Inc (BHC)

Over the past 90 days, Bausch Health Companies Inc. has seen five insider transactions, all of which were sales totaling approximately $668,388. These transactions occurred following the company's July 2026 earnings report, which showed a 24.75% earnings beat. The stock has experienced an 11.7% price increase over the last three months.
Ticker: BHC Exchange: TOR


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bausch Health Companies Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Sale 3 Aug 2026
Value US$4,412,657.60 | Price 270.44 | Shares 77,463 (-3.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-04 2026-08-03 S Sale

Senior Officer of Issuer

Officer
77,463 -3.3%
270.44
US$4,412,658
77,463 -3.3% 270.44 US$4,412,658
2026-08-04 2026-07-31 S Sale

Senior Officer of Issuer

Officer
20,362 +4.7%
350.90
US$4,316,866
20,362 +4.7% 350.90 US$4,316,866
2026-05-20 2026-05-19 S Sale

Director of Issuer

Non-Executive Director
45,654 -48.3%
363.16
US$1,491,238
45,654 -48.3% 363.16 US$1,491,238
2026-05-20 2026-05-19 PlS Planned sale Non-Executive Director
24,456 -33.1%
5.43
US$132,796
24,456 -33.1% 5.43 US$132,796
2026-05-19 2026-05-19 PrS Proposed sale

Director

Non-Executive Director
24,456
5.43
US$132,796
24,456 5.43 US$132,796
2026-05-01 2026-04-30 S Sale

Senior Officer of Issuer

Officer
20,000 -6.6%
6.00
US$120,000
20,000 -6.6% 6.00 US$120,000
2026-03-04 2026-03-03 S Sale

Senior Officer of Issuer

Officer
4,420 -1.8%
5.77
US$25,503
4,420 -1.8% 5.77 US$25,503
2026-03-03 2026-03-03 PlS Planned sale

EVP, General Counsel

Officer
4,420 -0.7%
5.77
US$25,503
4,420 -0.7% 5.77 US$25,503
2026-03-03 2026-03-03 PrS Proposed sale

Officer

Officer
4,420
5.77
US$25,503
4,420 5.77 US$25,503
2026-03-04 2026-03-02 S Sale

Senior Officer of Issuer

Officer
6,856 -2.7%
5.78
US$39,628
6,856 -2.7% 5.78 US$39,628
2026-03-03 2026-03-02 PlS Planned sale

EVP, General Counsel

Officer
6,856 -0.9%
5.78
US$39,628
6,856 -0.9% 5.78 US$39,628
2026-03-02 2026-03-02 PrS Proposed sale

Officer

Officer
6,856
5.78
US$39,628
6,856 5.78 US$39,628
2026-03-02 2026-02-27 S Sale

Senior Officer of Issuer

Officer
8,388 -3.7%
5.95
US$49,909
8,388 -3.7% 5.95 US$49,909
2026-02-27 2026-02-27 PlS Planned sale

EVP, General Counsel

Officer
8,388 -1.0%
5.95
US$49,909
8,388 -1.0% 5.95 US$49,909
2026-02-27 2026-02-27 PrS Proposed sale

Officer

Officer
8,388
5.95
US$49,909
8,388 5.95 US$49,909
2025-12-08 2025-12-03 S Sale

Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
11,500
7.00
US$80,500
11,500 7.00 US$80,500
2025-12-08 2025-12-03 S Sale

Senior Officer of Issuer

Officer
21,568
7.00
US$150,976
21,568 7.00 US$150,976
2025-11-28 2025-11-25 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
2,500,000
6.25
US$15,625,000
2,500,000 6.25 US$15,625,000
2025-11-28 2025-11-25 B Purchase Large shareholder
2,500,000 +3.5%
6.25
US$15,625,000
2,500,000 +3.5% 6.25 US$15,625,000
2025-09-08 2025-09-08 PrS Proposed sale

Officer

Officer
13,370
7.31
US$97,735
13,370 7.31 US$97,735
2025-09-08 2025-09-08 S Sale

Senior Officer of Issuer

Officer
13,370 -6.4%
7.31
US$97,735
13,370 -6.4% 7.31 US$97,735
2025-09-08 2025-09-08 PlS Planned sale

EVP, General Counsel

Officer
13,370 -2.6%
7.31
US$97,735
13,370 -2.6% 7.31 US$97,735
2025-08-27 2025-08-21 S Sale

Director of Issuer

Non-Executive Director
15,912 -45.0%
7.66
US$121,886
15,912 -45.0% 7.66 US$121,886
2025-08-22 2025-08-21 S Sale Non-Executive Director
15,912 -17.7%
7.66
US$121,886
15,912 -17.7% 7.66 US$121,886
2025-08-21 2025-08-21 PrS Proposed sale

Director

Non-Executive Director
15,912
7.66
US$121,888
15,912 7.66 US$121,888
2025-08-15 2025-08-14 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
34,721,118 +1070.6%
9.00
US$312,490,062
34,721,118 +1070.6% 9.00 US$312,490,062
2025-08-14 2025-08-14 B Purchase Non-Executive Director
34,721,118 +96.4%
9.00
US$312,490,062
34,721,118 +96.4% 9.00 US$312,490,062
2025-08-13 2025-08-13 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
86,409 +2.7%
7.06
US$610,048
86,409 +2.7% 7.06 US$610,048
2025-08-13 2025-08-13 B Purchase Non-Executive Director
86,409 +0.2%
7.06
US$610,048
86,409 +0.2% 7.06 US$610,048
2025-08-13 2025-08-12 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,156,640 +57.8%
6.88
US$7,957,683
1,156,640 +57.8% 6.88 US$7,957,683
2025-08-13 2025-08-12 B Purchase Non-Executive Director
1,156,640 +3.3%
6.88
US$7,957,683
1,156,640 +3.3% 6.88 US$7,957,683
2025-08-13 2025-08-11 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
2,000,000
6.35
US$12,700,000
2,000,000 6.35 US$12,700,000
2025-08-13 2025-08-11 B Purchase Non-Executive Director
2,000,000 +6.1%
6.35
US$12,700,000
2,000,000 +6.1% 6.35 US$12,700,000
2025-06-17 2025-06-13 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,782,030 +13.1%
5.94
US$10,585,258
1,782,030 +13.1% 5.94 US$10,585,258
2025-06-17 2025-06-13 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,782,029 +28.6%
5.94
US$10,585,252
1,782,029 +28.6% 5.94 US$10,585,252
2025-06-17 2025-06-13 B Purchase Non-Executive Director
3,564,059 +12.2%
5.94
US$21,170,510
3,564,059 +12.2% 5.94 US$21,170,510
2025-06-16 2025-06-12 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
502,688 +3.8%
5.47
US$2,749,703
502,688 +3.8% 5.47 US$2,749,703
2025-06-16 2025-06-12 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
502,688 +8.8%
5.47
US$2,749,703
502,688 +8.8% 5.47 US$2,749,703
2025-06-12 2025-06-12 B Purchase Non-Executive Director
1,005,376 +3.6%
5.47
US$5,499,407
1,005,376 +3.6% 5.47 US$5,499,407
2025-06-16 2025-06-11 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
514,549 +4.1%
5.24
US$2,696,237
514,549 +4.1% 5.24 US$2,696,237
2025-06-16 2025-06-11 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
514,549 +9.9%
5.24
US$2,696,237
514,549 +9.9% 5.24 US$2,696,237
2025-06-12 2025-06-11 B Purchase Non-Executive Director
1,029,098 +3.8%
5.24
US$5,392,474
1,029,098 +3.8% 5.24 US$5,392,474
2025-06-14 2025-06-10 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
754,134
5.05
US$3,808,377
754,134 5.05 US$3,808,377
2025-06-12 2025-06-10 B Purchase Non-Executive Director
754,134 +2.9%
5.05
US$3,808,377
754,134 +2.9% 5.05 US$3,808,377
2024-12-03 2024-12-02 PlS Planned sale

EVP, General Counsel

Officer
440 -0.1%
8.35
US$3,674
440 -0.1% 8.35 US$3,674
2024-12-02 2024-12-02 PrS Proposed sale

Officer

Officer
440
8.35
US$3,674
440 8.35 US$3,674
2024-09-09 2024-09-06 PlS Planned sale

EVP, General Counsel

Officer
13,370 -3.0%
6.21
US$83,028
13,370 -3.0% 6.21 US$83,028
2024-09-09 2024-09-06 S Sale

Senior Officer of Issuer

Officer
13,370 -10.0%
6.21
US$83,028
13,370 -10.0% 6.21 US$83,028
2024-09-06 2024-09-06 PrS Proposed sale

Officer

Officer
13,370
6.21
US$83,028
13,370 6.21 US$83,028
2024-03-04 2024-03-04 PrS Proposed sale

Officer

Officer
6,313
9.80
US$61,867
6,313 9.80 US$61,867
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
133 -0.0%
9.80
US$1,303
133 -0.0% 9.80 US$1,303
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
1,561 -0.3%
9.80
US$15,298
1,561 -0.3% 9.80 US$15,298
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
199 -0.0%
9.80
US$1,950
199 -0.0% 9.80 US$1,950
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
4,420 -0.9%
9.80
US$43,316
4,420 -0.9% 9.80 US$43,316
2023-12-05 2023-12-05 PrS Proposed sale

Officer

Officer
220
7.38
US$1,624
220 7.38 US$1,624
2023-12-05 2023-12-05 PlS Planned sale

EVP, General Counsel

Officer
220 -0.1%
7.38
US$1,624
220 -0.1% 7.38 US$1,624
2023-11-07 2023-11-06 S Sale

Senior Officer of Issuer

Officer
43 -0.1%
7.61
US$327
43 -0.1% 7.61 US$327
2023-11-06 2023-11-06 PrS Proposed sale

Officer

Officer
43
7.61
US$327
43 7.61 US$327
2023-11-06 2023-11-06 PlS Planned sale

EVP, General Counsel

Officer
43 -0.0%
7.61
US$327
43 -0.0% 7.61 US$327
2023-09-06 2023-09-06 PrS Proposed sale

Officer

Officer
6,685
8.28
US$55,352
6,685 8.28 US$55,352
2023-09-06 2023-09-06 PlS Planned sale

EVP, General Counsel

Officer
6,685 -1.7%
8.28
US$55,352
6,685 -1.7% 8.28 US$55,352
2023-03-06 2023-03-06 PrS Proposed sale

Officer

Officer
495
9.17
US$4,539
495 9.17 US$4,539
2023-03-01 2023-02-28 S Sale

Senior Officer of Issuer

Officer
292 -1.3%
9.32
US$2,721
292 -1.3% 9.32 US$2,721
2023-03-01 2023-02-28 PlS Planned sale

EVP, General Counsel

Officer
292 -0.1%
9.32
US$2,721
292 -0.1% 9.32 US$2,721
2022-04-15 2022-04-14 PlS Planned sale

U.S. President-Pharma Business

Officer
1,595 -1.7%
22.19
US$35,393
1,595 -1.7% 22.19 US$35,393
2022-03-16 2022-03-15 PlS Planned sale

U.S. President-Pharma Business

Officer
4,846 -5.0%
22.20
US$107,581
4,846 -5.0% 22.20 US$107,581
2022-03-10 2022-03-08 PlS Planned sale

Pres&Co-Head Bausch&Lomb/Int'l

Officer
3,889 -4.0%
21.76
US$84,625
3,889 -4.0% 21.76 US$84,625
2022-03-04 2022-03-02 PlS Planned sale

Pres&Co-Head Bausch&Lomb/Int'l

Officer
11,077 -9.9%
23.37
US$258,869
11,077 -9.9% 23.37 US$258,869
2022-03-04 2022-03-02 PlS Planned sale

U.S. President-Pharma Business

Officer
1,595 -2.4%
23.37
US$37,275
1,595 -2.4% 23.37 US$37,275
2022-03-02 2022-03-01 PlS Planned sale

Pres&Co-Head Bausch&Lomb/Int'l

Officer
6,338 -5.3%
23.82
US$150,971
6,338 -5.3% 23.82 US$150,971
2022-02-17 2022-02-15 PlS Planned sale

U.S. President-Pharma Business

Officer
3,251 -5.1%
25.02
US$81,340
3,251 -5.1% 25.02 US$81,340
2022-01-20 2022-01-18 PlS Planned sale

U.S. President-Pharma Business

Officer
3,251 -4.9%
26.63
US$86,574
3,251 -4.9% 26.63 US$86,574
2021-12-02 2021-11-30 B Purchase Non-Executive Director
10,000 +inf%
24.17
US$241,699
10,000 +inf% 24.17 US$241,699
2021-12-02 2021-11-30 B Purchase Non-Executive Director
50,000 +463.8%
24.24
US$1,211,825
50,000 +463.8% 24.24 US$1,211,825
2021-06-15 2021-06-11 S Sale

EVP & Chief Financial Officer

Officer
17,000 -12.7%
31.68
US$538,586
17,000 -12.7% 31.68 US$538,586